Home
Bergen Gynecologic Cancer Research Group

Warning message

There has not been added a translated version of this content. You can either try searching or go to the "area" home page to see if you can find the information there

 ADDIN EN.REFLIST Berg, A., K. E. Fasmer, K. K. Mauland, S. Ytre-Hauge, E. A. Hoivik, J. A. Husby, I. L. Tangen, J. Trovik, M. K. Halle, K. Woie, L. Bjorge, A. Bjornerud, H. B. Salvesen, H. M. Werner, C. Krakstad and I. S. Haldorsen (2016). "Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer." Oncotarget 7(43): 69844-69856.

 

Bollineni, V. R., S. Ytre-Hauge, O. Bollineni-Balabay, H. B. Salvesen and I. S. Haldorsen (2016). "High Diagnostic Value of 18F-FDG PET/CT in Endometrial Cancer: Systematic Review and Meta-Analysis of the Literature." J Nucl Med 57(6): 879-885.

 

Cheng, T. H., D. J. et l… Cunningham, P. D. Pharoah, A. M. Dunning, S. L. Edwards, D. F. Easton, I. Tomlinson and A. B. Spurdle (2016). "Five endometrial cancer risk loci identified through genome-wide association analysis." Nat Genet 48(6): 667-674.

 

Cuellar-Partida, et al… and S. MacGregor (2016). "Assessing the genetic architecture of epithelial ovarian cancer histological subtypes." Hum Genet 135(7): 741-756.

 

Dixon, S. C.,et al…., A. Dansonka-Mieszkowska, A. Budzilowska, B. Spiewankiewicz, P. M. Webb and C. Ovarian Cancer Association (2016). "Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study." Int J Epidemiol 45(3): 884-895.

 

Gansmo, L. B., M. Bjornslett, M. K. Halle, H. B. Salvesen, A. Dorum, E. Birkeland, K. Hveem, P. Romundstad, L. Vatten, P. E. Lonning and S. Knappskog (2016). "The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian-but not endometrial cancer." Tumour Biol 37(8): 10697-10702.

 

Gibson, W. J., E. A. Hoivik, M. K. Halle, A. Taylor-Weiner, A. D. Cherniack, A. Berg, F. Holst, T. I. Zack, H. M. Werner, K. M. Staby, M. Rosenberg, I. M. Stefansson, K. Kusonmano, A. Chevalier, K. K. Mauland, J. Trovik, C. Krakstad, M. Giannakis, E. Hodis, K. Woie, L. Bjorge, O. K. Vintermyr, J. A. Wala, M. S. Lawrence, G. Getz, S. L. Carter, R. Beroukhim and H. B. Salvesen (2016). "The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis." Nat Genet 48(8): 848-855.

 

Haldorsen, I. S. and H. B. Salvesen (2016). "What Is the Best Preoperative Imaging for Endometrial Cancer?" Curr Oncol Rep 18(4): 25.

 

Hampras, S. S., et al….and K. B. Moysich (2016). "Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer." Oncotarget 7(43): 69097-69110.

 

Holst, F., E. A. Hoivik, W. J. Gibson, A. Taylor-Weiner, S. E. Schumacher, Y. W. Asmann, P. Grossmann, J. Trovik, B. M. Necela, E. A. Thompson, M. Meyerson, R. Beroukhim, H. B. Salvesen and A. D. Cherniack (2016). "Corrigendum: Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth." Sci Rep 6: 27960.

 

Holst, F., E. A. Hoivik, W. J. Gibson, A. Taylor-Weiner, S. E. Schumacher, Y. W. Asmann, P. Grossmann, J. Trovik, B. M. Necela, E. A. Thompson, M. Meyerson, R. Beroukhim, H. B. Salvesen and A. D. Cherniack (2016). "Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth." Sci Rep 6: 25521.

 

Kar, S. P.,et al….  P. D. Pharoah and D. Lambrechts (2016). "Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types." Cancer Discov 6(9): 1052-1067.

 

Lawrenson, K., S. et al…, A. C. Antoniou and S. A. Gayther (2016). "Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus." Nat Commun 7: 12675.

 

Meeks, H. D., H. et al….  A. B. Spurdle and D. E. Goldgar (2016). "BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers." J Natl Cancer Inst 108(2).

 

Ong, J. S., et al…  and S. MacGregor (2016). "Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study." Int J Epidemiol 45(5): 1619-1630.

 

Ovarian Cancer Association Consortium, et al… M. J. Hooning and E. L. Goode (2016). "No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer." Gynecol Oncol 141(2): 386-401.

 

Painter, J. N., S. Kaufmann, T. A. O'Mara, K. M. Hillman, H. Sivakumaran, H. Darabi, T. H. Cheng, J. Pearson, S. Kazakoff, N. Waddell, E. A. Hoivik, E. L. Goode, R. J. Scott, I. Tomlinson, A. M. Dunning, D. F. Easton, J. D. French, H. B. Salvesen, P. M. Pollock, D. J. Thompson, A. B. Spurdle and S. L. Edwards (2016). "A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 Binding." Am J Hum Genet 98(6): 1159-1169.

 

Painter, J. N., et al…. and. National Study of Endometrial Cancer Genetics and G. Australian National Endometrial Cancer Study (2016). "Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer." Cancer Epidemiol Biomarkers Prev 25(11): 1503-1510.

 

Southey, M. C.,  et al….D. F. Easton and R. L. Milne (2016). "PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS." J Med Genet 53(12): 800-811.

 

Tangen, I. L., T. B. Onyango, R. Kopperud, A. Berg, M. K. Halle, A. M. Oyan, H. M. Werner, J. Trovik, K. H. Kalland, H. B. Salvesen and C. Krakstad (2016). "Androgen receptor as potential therapeutic target in metastatic endometrial cancer." Oncotarget 7(31): 49289-49298.

 

Thompson, D. J., et al…. A. B. Spurdle (2016). "CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer." Endocr Relat Cancer 23(2): 77-91.

 

van der Putten, L. J., N. C. Visser, K. van de Vijver, M. Santacana, P. Bronsert, J. Bulten, M. Hirschfeld, E. Colas, A. Gil-Moreno, A. Garcia, G. Mancebo, F. Alameda, J. Trovik, R. K. Kopperud, J. Huvila, S. Schrauwen, M. Koskas, F. Walker, V. Weinberger, L. Minar, E. Jandakova, M. P. Snijders, S. van den Berg-van Erp, X. Matias-Guiu, H. B. Salvesen, F. Amant, L. F. Massuger and J. M. Pijnenborg (2016). "L1CAM expression in endometrial carcinomas: an ENITEC collaboration study." Br J Cancer 115(6): 716-724.

 

Yang, J. Y., H. M. Werner, J. Li, S. N. Westin, Y. Lu, M. K. Halle, J. Trovik, H. B. Salvesen, G. B. Mills and H. Liang (2016). "Integrative Protein-Based Prognostic Model for Early-Stage Endometrioid Endometrial Cancer." Clin Cancer Res 22(2): 513-523.